Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
Follow SYK
Stryker Corporation (SYK) EV/FCF
As of 16 October 2026, Stryker Corporation (SYK) trades at a EV/FCF of 26.5×. Over the past ten years it has ranged from 18.6× (November 2016) to 301× (October 2017); the current reading is higher than 9% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 34.1× | (18.69%) |
| FY2024 | 42.0× | 7.49% |
| FY2023 | 39.0× | (23.72%) |
| FY2022 | 51.2× | 27.03% |
| FY2021 | 40.3× | 9.12% |
| FY2020 | 36.9× | (33.18%) |
| FY2019 | 55.2× | 73.74% |
| FY2018 | 31.8× | (51.87%) |
| FY2017 | 66.1× | 95.27% |
| FY2016 | 33.8× | (31.12%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 28.1× | (6.58%) |
| Mar 2026 | 30.1× | (11.76%) |
| Dec 2025 | 34.1× | (6.51%) |
| Sep 2025 | 36.5× | (11.20%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| PHG Koninklijke Philips N.V. compare | 16.1× |
| BSX Boston Scientific Corporation compare | 21.3× |
| MDT Medtronic PLC compare | 22.9× |
| DXCM DexCom, Inc. compare | 23.5× |
| STE STERIS plc compare | 24.7× |
| GEHC GE HealthCare Technologies Inc. compare | 25.9× |
| SYK Stryker Corporation | 26.5× |
| ABT Abbott Laboratories compare | 26.8× |
| EW Edwards Lifesciences Corporation compare | 33.4× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement